Multimorbidity in chronic disease: impact on health care resources and costs
- PMID: 27462182
- PMCID: PMC4939994
- DOI: 10.2147/RMHP.S97248
Multimorbidity in chronic disease: impact on health care resources and costs
Abstract
Effective and resource-efficient long-term management of multimorbidity is one of the greatest health-related challenges facing patients, health professionals, and society more broadly. The purpose of this review was to provide a synthesis of literature examining multimorbidity and resource utilization, including implications for cost-effectiveness estimates and resource allocation decision making. In summary, previous literature has reported substantially greater, near exponential, increases in health care costs and resource utilization when additional chronic comorbid conditions are present. Increased health care costs have been linked to elevated rates of primary care and specialist physician occasions of service, medication use, emergency department presentations, and hospital admissions (both frequency of admissions and bed days occupied). There is currently a paucity of cost-effectiveness information for chronic disease interventions originating from patient samples with multimorbidity. The scarcity of robust economic evaluations in the field represents a considerable challenge for resource allocation decision making intended to reduce the burden of multimorbidity in resource-constrained health care systems. Nonetheless, the few cost-effectiveness studies that are available provide valuable insight into the potential positive and cost-effective impact that interventions may have among patients with multiple comorbidities. These studies also highlight some of the pragmatic and methodological challenges underlying the conduct of economic evaluations among people who may have advanced age, frailty, and disadvantageous socioeconomic circumstances, and where long-term follow-up may be required to directly observe sustained and measurable health and quality of life benefits. Research in the field has indicated that the impact of multimorbidity on health care costs and resources will likely differ across health systems, regions, disease combinations, and person-specific factors (including social disadvantage and age), which represent important considerations for health service planning. Important priorities for research include economic evaluations of interventions, services, or health system approaches that can remediate the burden of multimorbidity in safe and cost-effective ways.
Keywords: burden; chronic disease; comorbidity; complexity; cost-effectiveness; economic.
Figures


Similar articles
-
Economic burden of multimorbidity among older adults: impact on healthcare and societal costs.BMC Health Serv Res. 2016 May 10;16:173. doi: 10.1186/s12913-016-1421-7. BMC Health Serv Res. 2016. PMID: 27160080 Free PMC article.
-
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426
-
Modeling the Economic Impact of Interventions for Older Populations with Multimorbidity: A Method of Linking Multiple Single-Disease Models.Med Decis Making. 2019 Oct;39(7):842-856. doi: 10.1177/0272989X19868987. Epub 2019 Aug 20. Med Decis Making. 2019. PMID: 31431188
-
Generalisability in economic evaluation studies in healthcare: a review and case studies.Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490. Health Technol Assess. 2004. PMID: 15544708 Review.
-
Economic evaluation of nurse practitioner and clinical nurse specialist roles: A methodological review.Int J Nurs Stud. 2017 Jul;72:71-82. doi: 10.1016/j.ijnurstu.2017.04.012. Epub 2017 May 4. Int J Nurs Stud. 2017. PMID: 28500955 Review.
Cited by
-
Survival, health care resource utilization and expenditures of first-line treatments for multiple myeloma patients ineligible for transplant in Taiwan.PLoS One. 2021 May 26;16(5):e0252124. doi: 10.1371/journal.pone.0252124. eCollection 2021. PLoS One. 2021. PMID: 34038463 Free PMC article.
-
Multimorbidity of communicable and non-communicable diseases in low- and middle-income countries: A systematic review.J Multimorb Comorb. 2022 Sep 1;12:26335565221112593. doi: 10.1177/26335565221112593. eCollection 2022 Jan-Dec. J Multimorb Comorb. 2022. PMID: 36081708 Free PMC article. Review.
-
Certified service dogs - A cost-effectiveness analysis appraisal.PLoS One. 2019 Sep 12;14(9):e0219911. doi: 10.1371/journal.pone.0219911. eCollection 2019. PLoS One. 2019. PMID: 31513601 Free PMC article.
-
Age-specific Multimorbidity Patterns and Burden on All-Cause Mortality and Public Direct Medical Expenditure: A Retrospective Cohort Study.J Epidemiol Glob Health. 2024 Sep;14(3):1077-1088. doi: 10.1007/s44197-024-00256-y. Epub 2024 Jun 13. J Epidemiol Glob Health. 2024. PMID: 38869775 Free PMC article.
-
Value configurations for balancing standardization and customization in chronic care: a qualitative study.BMC Health Serv Res. 2021 Aug 21;21(1):845. doi: 10.1186/s12913-021-06844-z. BMC Health Serv Res. 2021. PMID: 34416902 Free PMC article.
References
-
- Lehnert T, Heider D, Leicht H, et al. Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev. 2011;68(4):387–420. - PubMed
-
- Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177–187. - PubMed
-
- Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–724. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical